BGNE - BeiGene, Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
1,249,805
1,415,921
1,176,283
308,874
428,212
Cost of Revenue
1,886,468
1,926,983
1,624,145
1,365,534
998,528
Gross Profit
-636,663
-511,062
-447,862
-1,056,660
-570,316
Operating Expenses
Selling General and Administrative
1,255,369
1,277,852
990,123
600,176
388,249
Total Operating Expenses
1,256,119
1,278,603
990,873
601,022
389,575
Operating Income or Loss
-1,892,782
-1,789,665
-1,438,735
-1,657,682
-959,891
Total Other Income/Expenses Net
-253,873
-223,852
15,904
37,490
7,174
Income Before Tax
-2,116,876
-1,961,037
-1,438,588
-1,618,194
-943,586
Income Tax Expense
-12,180
42,778
-25,234
-17,671
6,992
Income from Continuing Operations
-2,104,696
-2,003,815
-1,413,354
-1,600,523
-950,578
Net Income
-2,104,696
-2,003,815
-1,413,354
-1,596,906
-948,628
Net Income available to common shareholders
-2,104,696
-2,003,815
-1,413,354
-1,596,906
-948,628
Basic EPS
-
-19.37
-15.21
-19.11
-15.86
Diluted EPS
-
-19.37
-15.21
-19.11
-15.86
Basic Average Shares
-
103,133
92,785
83,472
60,054
Diluted Average Shares
-
103,133
92,785
83,472
60,054
EBITDA
-
-1,788,914
-1,437,985
-1,656,836
-958,565